Delcath Systems, Inc. (DCTH)
9.34
+0.22
(+2.41%)
USD |
NASDAQ |
Feb 13, 14:18
Delcath Systems Cash from Investing (Quarterly) : -0.466M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | -191.00M |
| Danaher Corp. | -384.00M |
| CytoSorbents Corp. | 0.055M |
| Cardiac Biotech Solutions, Inc. | -- |
| Odyssey Health, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.772M |
| Cash from Financing (Quarterly) | 3.10M |
| Free Cash Flow | 12.04M |
| Free Cash Flow Per Share (Quarterly) | 0.1077 |
| Free Cash Flow to Equity (Quarterly) | 4.341M |
| Free Cash Flow to Firm (Quarterly) | 4.313M |
| Free Cash Flow Yield | 3.39% |